Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:03 pm Sale | 2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Atlas Venture Fund XI, L.P. | 1,963,529 5.600% | -242,883 (-11.01%) | Filing History |
| 2022-02-10 2:07 pm Sale | 2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO | JANUS HENDERSON GROUP PLC JHG | 3,163,622 9.100% | -329,797 (-9.44%) | Filing History |
| 2022-02-08 4:19 pm Purchase | 2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO | GOLDMAN SACHS GROUP INC GS | 1,776,192 5.100% | 1,776,192 (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO | BlackRock Inc. BLK | 1,944,122 5.600% | 1,944,122 (New Position) | Filing History |
| 2022-02-04 09:12 am Purchase | 2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Wellington Management Group LLP | 1,876,811 5.380% | 1,876,811 (New Position) | Filing History |
| 2021-12-13 4:58 pm Purchase | 2021-12-10 | 13G | Akero Therapeutics, Inc. AKRO | Point72 Asset Management, L.P. | 1,751,563 5.000% | 1,751,563 (New Position) | Filing History |
| 2021-06-30 4:17 pm Purchase | 2021-06-21 | 13G | Akero Therapeutics, Inc. AKRO | Skorpios Trust | 4,907,829 14.100% | 4,907,829 (New Position) | Filing History |
| 2021-06-28 8:56 pm Sale | 2021-06-21 | 13D | Akero Therapeutics, Inc. AKRO | ATP Life Science Ventures L.P. | 674,640 1.900% | -5,164,229 (-88.45%) | Filing History |
| 2021-05-07 4:13 pm Sale | 2021-05-04 | 13D | Akero Therapeutics, Inc. AKRO | venBio Global Strategic Fund II L.P. | 2,315,893 6.650% | -352,824 (-13.22%) | Filing History |